Skip to content

Effect of probiotic yogurt consumption on glycemic control and lipid profile in patients with type 2 diabetes mellitus: A double-blind randomized controlled trial

Effect of probiotic yogurt consumption on glycemic control and lipid profile in patients with type 2 diabetes mellitus: A double-blind randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220226054125N1
Enrollment
80
Registered
2022-07-30
Start date
2019-04-04
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of probiotic yogurt consumption on glycemic control and lipid profile in patients with type 2 diabetes mellitus. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: The subjects of the test group receive 200 grams of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis daily for three months. Intervention 2: People in t

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria included patients with T2DM low density lipoprotein-cholesterol (LDL-c) equal to or greater than 100 mg/dl age between 30-60 years taking metformin and Gli Banglamide tables with correct gastrointestinal function according to patient not taking blood lipid lowering drugs

Exclusion criteria

Exclusion criteria: The inclusion criteria included patients with T2DM low density Lipoprotein-cholesterol (LDL-c) equal to or greater than 100 mg/dl age between 30-60 years taking metformin and Gli Banglamide tables with correct gastrointestinal function according to patient not taking blood lipid lowering drugs

Design outcomes

Primary

MeasureTime frame
Blood sugar. Timepoint: Before and after study. Method of measurement: Using Pars Azmoun commercial kits.;Hemoglobin A1c. Timepoint: Before and after study. Method of measurement: Using Pars Azmoun commercial kits.;Cholesterol and Triglyceride. Timepoint: Before and after study. Method of measurement: By photometric method using Pars Azmoun commercial kits.;HDL. Timepoint: Before and after study. Method of measurement: By photometric method using Pars Azmoun commercial kits.;LDL. Timepoint: Before and after study. Method of measurement: By photometric method using Pars Azmoun commercial kits.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Salari Sharif

Yazd University of Medical Sciences

microb.5656@gmail.com+98 35 3824 1755

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 12, 2026